Preliminary results of a Neoadjuvant combo-immunotherapy with ipilimumab and nivolumab in locally advanced or limited metastatic melanoma

被引：0
|
作者：
Ferrucci, Pier Francesco [1 ]
Pala, Laura [1 ]
Conforti, Fabio [1 ]
Nezi, Luigi [2 ]
Manzo, Teresa [2 ]
Cocorocchio, Emilia [1 ]
机构：
[1] European Inst Oncol, Melanoma Unit, Milan, Italy
[2] European Inst Oncol, Dept Expt Oncol, Milan, Italy
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2020年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
15
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in locally advanced or oligometastatic melanoma: Preliminary results
    Cocorocchio, E.
    Pala, L.
    Nezi, L.
    Manzo, T.
    Mazzarella, L.
    Fiorenza, L.
    Gandini, S.
    Conforti, F.
    Mazzarol, G.
    Queirolo, P.
    Pennacchioli, E.
    Orsolini, G. M.
    Fierro, M. T.
    Ribero, S.
    Senetta, R.
    Fava, P.
    Picciotto, F.
    Caliendo, V.
    Quaglino, P.
    Ferrucci, P. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S765 - S766
  • [2] Neoadjuvant Ipilimumab/Nivolumab combination in locally advanced or oligometastatic melanoma
    Ferrucci, Pier Francesco
    Lanfrancone, Luisa
    Mazzarella, Luca
    Nezi, Luigi
    Duso, Bruno Achutti
    Manzo, Teresa
    Lotti, Fiorenza
    Gandini, Sara
    Orsolini, Gianmarco
    Pennacchioli, Elisabetta
    Gnagnarella, Patrizia
    Fierro, Maria Teresa
    Senetta, Rebecca
    Riviello, Concetta
    Caliendo, Virginia
    Quaglino, Pietro
    Mazzarol, Giovanni
    Bonizzi, Giuseppina
    Cocorocchio, Emilia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (SUPPL 1)
  • [3] Neoadjuvant Use of Ipilimumab in Locally Advanced Melanoma
    Howie, Lynn J.
    Tyler, Douglas S.
    Salama, April K. S.
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 112 (08) : 841 - 843
  • [4] Neoadjuvant Immunotherapy for Locally Advanced Melanoma
    Pelster, Meredith S.
    Amaria, Rodabe N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (02)
  • [5] Neoadjuvant Immunotherapy for Locally Advanced Melanoma
    Meredith S. Pelster
    Rodabe N. Amaria
    Current Treatment Options in Oncology, 2020, 21
  • [6] Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome
    Cocorocchio, E.
    Nezi, L.
    Gandini, S.
    Manzo, T.
    Mazzarella, L.
    Lotti, F.
    Pala, L.
    Gnagnarella, P.
    Conforti, F.
    Pennacchioli, E.
    Fierro, M. T.
    Ribero, S.
    Senetta, R.
    Picciotto, F.
    Caliendo, V.
    Quaglino, P.
    Mazzarol, G.
    Orsolini, G. M.
    Prestianni, P.
    Ferrucci, P. F.
    ANNALS OF ONCOLOGY, 2021, 32 : S889 - S890
  • [7] Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease
    Weber, J.
    Glutsch, V.
    Geissinger, E.
    Haug, L.
    Lock, J. F.
    Schneider, F.
    Kneitz, H.
    Goebeler, M.
    Schilling, B.
    Gesierich, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (03) : 559 - 563
  • [8] Autoimmune polyradiculitis due to combination immunotherapy with ipilimumab and nivolumab for the treatment of metastatic melanoma
    Lasocki, Arian
    Smith, Kortnye
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 74 : 240 - 241
  • [9] Treatment Outcomes of Neoadjuvant Immunotherapy in Patients with Locally Advanced Melanoma
    Mahuron, K.
    Levine, L.
    Daud, A.
    Alvarado, M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S7 - S7
  • [10] Development of systemic sarcoidosis during double immunotherapy with nivolumab/ipilimumab in metastatic malignant melanoma
    Adam, L.
    Yordanova, K.
    Saternus, R.
    Vogt, T.
    Pfoehler, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 54 - 54
12345